Q32 Bio Inc.
QTTB
Jodie situation report
Q32 Bio Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- QTTB's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if QTTB's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind QTTB
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AKBAAkebia Therapeutics, Inc.partnerMar 10, 2026 ▾
“On November 28, 2025, in connection with the ADX-097 Asset Sale, the Colorado License Agreement (defined in Note 10) was amended and restated and all of the Company’s rights and obligations thereunder were transferred to Akebia.”
BMYBristol-Myers Squibb CompanypartnerMar 10, 2026 ▾
“In particular, we depend substantially on our license agreement with Bristol Myers Squibb Company (“BMS”), under which we in-license patent rights and know-how that cover bempikibart (the “BMS Agreement”), and The Regents of the University of Colorado (the “C…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
QTTB is currently a Follower in the organic co-movement group Biotech and Energy. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for QTTB; it is not active in the latest market snapshot.